In line with a Biden administration proposal, pharmaceutical giant Eli Lilly is cutting the price of its most commonly prescribed insulins by 70 percent and capping out-of-pocket costs at $35 or less per month.
"While the current healthcare system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone and that needs to change," said CEO David A. Ricks. "The aggressive price cuts we're announcing today should make a real difference for Americans with diabetes. Because these price cuts will take time for the insurance and pharmacy system to implement, we are taking the additional step to immediately cap out-of-pocket costs for patients who use Lilly insulin and are not covered by the recent Medicare Part D cap."
Here is a list of the drugs seeing price cuts, via Eli Lilly:
"We are driving for change in repricing older insulins, but we know that 7 out of 10 Americans don't use Lilly insulin," said Ricks. We are calling on policymakers, employers and others to join us in making insulin more affordable."
The company said it will launch a nationwide awareness campaign in the coming weeks to spread the word about its new lower costs.
Activists have long called for more affordable insulin, which even with insurance can place a financial burden on those in need. The American Diabetes Association has found that there are approximately $15 billion in excess costs for insulin in 2017.
If you return to the office after working from home and feel like you're spending more money, you're not alone this year. That's according to a new report.
New York is trying to restrict algorithms that target young users on social media platforms, introducing two new bills that are designed to protect children's mental health.
Delta Airlines today reported third-quarter profits that beat expectations, boosting its full-year growth outlook, as the carrier earnings increased about 60% to $1.1 billion.
Millions of Social Security recipients will get a 3.2% increase in their benefits in 2024, far less than this year's historic boost and reflecting moderating consumer prices.
Design and lifestyle company Apartment Therapy has brought back its annual Small/Cool NYC exhibit to showcase some of the biggest interior design trends. Maxwell Ryan, founder of Apartment Therapy, joined Cheddar News to show some of the designs the company has come up with as well as some unique choices for living spaces of any size.
